| 查看: 2407 | 回复: 8 | ||||
[交流]
关于Biomaterials投稿
|
|
第一次投Biomaterials,有好多问题不是太懂,谁投过给些建议。 1.实验数据是不是放在文章的最后面 2.A template for the covering letter is found on the Biomaterials website.我没找到,想问一下你们在哪找到的 |
» 猜你喜欢
青基如何破局
已经有7人回复
有多少人是今天查系统知道结果的?
已经有17人回复
基金不中,共勉
已经有10人回复
国自然面上复盘~欢迎讨论
已经有11人回复
为什么资助数各大高校都创新高,自己申请怎么就这么难
已经有7人回复
基金未中,这种答复是模板吗?
已经有6人回复
看板上这么多中的,有点像50人群里49个人都是骗子的那种感觉……
已经有6人回复
导师吐槽:我怎么摊上了这么个极品研究生!
已经有6人回复
怎么看青基中了没有啊
已经有5人回复
梦想
已经有3人回复
» 本主题相关价值贴推荐,对您同样有帮助:
关于一篇文献的题目
已经有5人回复
2012 SCI impact factor 生物材料类 评点
已经有9人回复
论文投稿刊物选择
已经有1人回复
» 抢金币啦!回帖就可以得到:
发点金币玩
+5/605
面上得中
+1/470
2026年工程管理与智慧城市国际会议 (EMSC 2026)
+1/231
北京化工大学何静教授团队诚聘青年英才和博士后
+1/95
欢迎报考中科院苏州纳米所的氢能、燃料电池方向的博士生!(长期有效)
+1/57
欢迎保送和统考中科院苏州纳米所的氢能、燃料电池方向的研究生!(长期有效)
+1/56
中国科学院苏州纳米技术与纳米仿生研究所 仿生自适应智能系统实验室招收联培生
+1/39
现在生物医药相关有什么兼职可以做吗?
+1/35
国家蛋白质科学中心(北京),招收分析化学、药学和蛋白质组代谢组学博士研究生
+1/18
国家蛋白质科学中心(北京),招收分析化学、药学和蛋白质组代谢组学博士研究生
+1/17
新审查指南堵死了"一案双申"的老路,实用新型和发明只能二选一了?
+1/13
浙江大学医学院黄浩杰教授团队招聘4-5名博士后
+1/7
收到青A意见了,这句评语给我看破防了,你是多少年远离正经科研圈了呀??
+1/5
南京大学 智能驱动与感知材料实验室 诚招申请考核博士生/科研助理/博士后
+1/4
中科院大连化学物理研究所 招聘 催化剂研发方向 科研助理 2名
+1/4
细胞治疗全流程关键检测技术与研究策略
+1/3
南方医科大学深圳医院陈烨/余涛教授课题组联合培养博士后招聘
+1/2
重大突破!酶法合成破解生物法DNA合成原料“卡脖子”难题
+1/1
量子物理团队招收博士生与博士后
+1/1
EI会议征稿!第二届先进复合材料、聚合物和纳米技术国际学术会议(ACMPN 2027)
+1/1
nono2009
超级版主 (文学泰斗)
-

专家经验: +21105 - SEPI: 10
- 应助: 28684 (院士)
- 贵宾: 513.911
- 金币: 2555230
- 帖子: 1602255
- 在线: 65200.9小时
- 虫号: 827383
★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
|
楼主是看的这里吗:http://www.elsevier.com/journals ... 2/guide-for-authors 这么没有查到你说的A template for the covering letter is found on the Biomaterials website |
2楼2012-11-17 19:30:02
3楼2012-11-17 22:01:53
★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
|
亲,你可以在EES的主页上的右边栏上点Author declaration,然后就会直接下载一个word版本的author declaration,而 A template for the covering letter will be found at the end of this document:顺便给你复制了一个,因为好还不会用附件啊 We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4楼2012-11-17 22:38:10
5楼2012-11-18 09:19:31
6楼2013-04-22 16:56:56
7楼2013-04-23 08:50:25
8楼2013-04-23 13:28:19
9楼2013-04-24 19:43:46









回复此楼